Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Barrett Esophagus

Barrett Esophagus

Part of Esophageal Diseases

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Barrett Esophagus

17 trials tracked for Barrett Esophagus.

17Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 5 Other / NA 12
  1. Phase 2 Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia Completed
  2. Phase 2 Endoscopic Therapy of Early Cancer in Barretts Esophagus Completed
  3. Phase 2 Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus Completed
  4. Phase 2 Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus Completed
  5. Phase 2 Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer Completed
  6. N/A Micro-Layer Ablation of Barrett's Metaplasia- A Two-Phase, Multi-Center Trial - Extension of Follow-up to 5 Years Completed
Show 11 more trials
  1. N/A Non-endoscopic Brushing of the Esophagus Using a Non-endoscopic Inflatable Balloon of the Esophagus in Screening for Barrett Esophagus Completed
  2. N/A a/LCI-OCT Pilot in Esophagus Completed
  3. N/A CLE for Assessment of Neoplasia After Mucosal Ablation or Resection of Gastrointestinal Neoplasia Completed
  4. N/A An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy Completed
  5. N/A Detection Of Neoplastic Tissue in Barrett's Esophagus With In vivO Probe-based Confocal Endomicroscopy Completed
  6. N/A OCT Pilot in Esophagus Completed
  7. N/A Ablation of Intestinal Metaplasia Containing Dysplasia Completed
  8. N/A Clinical Utility of a Non Endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barrett's Esophagus in At Risk Population Completed
  9. N/A Patient Acceptance and Preference Among Screening Modalities for Detection of Barrett's Esophagus Completed
  10. N/A A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus Completed
  11. N/A HALO Patient Registry: Ablation of Barrett's Esophagus Completed

Showing the 17 most-cited and recently-updated of 17 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Multifocal cryoballoon ablation achieves high eradication rates in Barrett esophagus with dysplasia
ENT (Otolaryngology)
Multifocal cryoballoon ablation achieves high eradication rates in Barrett esophagus with dysplasia Freezing Away Esophageal Cancer Before It Starts
A prospective European multicenter study of 107 patients with Barrett esophagus segments (Prague classification C≤2M≤5) and dysplasia or ear…
A targeted freezing procedure may offer people with Barrett's esophagus a safe, highly effective way to destroy pre-cancerous cells before t…
Apr 14, 2026

Research across Esophageal Diseases

Related studies from across the Esophageal Diseases family.

Aberrant p53 expression is associated with higher risk of progression to advanced neoplasia in Barrett's esophagus
ENT (Otolaryngology) Meta-analysis
Aberrant p53 expression is associated with higher risk of progression to advanced neoplasia in Barrett's esophagus p53 Expression Linked to Higher Risk of Barrett's Esophagus Progression
This meta-analysis of 27 studies evaluates p53 immunohistochemistry as a biomarker for progression to high-grade dysplasia and esophageal ad…
A review of 27 studies shows that abnormal p53 expression is linked to a higher risk of cancer progression in patients with Barrett's esopha…
Oct 8, 2026
Narrative review discusses AI-driven pathology models for esophageal cancer and Barrett's esophagus management
Oncology Sys. Review
Narrative review discusses AI-driven pathology models for esophageal cancer and Barrett's esophagus management AI Pathology Models May Help Screen Barrett's Esophagus and Esophageal Cancer
This narrative review examines the role of AI-driven pathology models in managing patients with esophageal cancer and Barrett's esophagus. T…
A narrative review suggests AI-driven pathology models could improve early screening and diagnosis for Barrett's esophagus and esophageal ca…
Frontiers May 20, 2026
Meta-analysis finds TSP-9 test predicts progression to HGD/EAC in Barrett's esophagus
ENT (Otolaryngology) Meta-analysis
Meta-analysis finds TSP-9 test predicts progression to HGD/EAC in Barrett's esophagus TSP-9 test predicts disease progression in Barrett's esophagus patients with high accuracy
A systematic review and meta-analysis of 699 patients with Barrett's esophagus found the Tissue Systems Pathology (TSP-9) test was associate…
A new test for Barrett's esophagus accurately predicts who is at high risk of developing serious esophageal cancer, helping doctors focus ca…
Apr 8, 2026